desonide 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| steroids for topical use, acetal derivatives | 3135 | 638-94-8 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 4, 1972 | FDA | PERRIGO NEW YORK |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Macular degeneration | 681.95 | 21.87 | 158 | 2664 | 14230 | 50588072 |
| Drug ineffective | 143.82 | 21.87 | 199 | 2623 | 819134 | 49783168 |
| Psoriasis | 137.70 | 21.87 | 70 | 2752 | 68930 | 50533372 |
| Dermatitis atopic | 45.72 | 21.87 | 14 | 2808 | 3572 | 50598730 |
| Cutaneous T-cell lymphoma | 44.64 | 21.87 | 11 | 2811 | 1253 | 50601049 |
| Eczema | 31.10 | 21.87 | 18 | 2804 | 22684 | 50579618 |
| Iridoschisis | 29.17 | 21.87 | 4 | 2818 | 14 | 50602288 |
| Chronic sinusitis | 24.10 | 21.87 | 10 | 2812 | 6135 | 50596167 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Psoriasis | 92.99 | 22.99 | 43 | 1723 | 32184 | 29540577 |
| Hepatic lesion | 26.02 | 22.99 | 9 | 1757 | 3141 | 29569620 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Psoriasis | 150.14 | 20.04 | 74 | 3349 | 71629 | 64423680 |
| Dermatitis atopic | 41.13 | 20.04 | 13 | 3410 | 3863 | 64491446 |
| Cutaneous T-cell lymphoma | 38.41 | 20.04 | 11 | 3412 | 2341 | 64492968 |
| Application site pain | 32.01 | 20.04 | 11 | 3412 | 4237 | 64491072 |
| Product dose omission issue | 30.24 | 20.04 | 44 | 3379 | 194703 | 64300606 |
| Iridoschisis | 29.36 | 20.04 | 4 | 3419 | 14 | 64495295 |
| Macular degeneration | 28.83 | 20.04 | 11 | 3412 | 5699 | 64489610 |
| Pruritus | 27.75 | 20.04 | 55 | 3368 | 312345 | 64182964 |
| Dry skin | 24.72 | 20.04 | 21 | 3402 | 51140 | 64444169 |
| Dry eye | 23.02 | 20.04 | 16 | 3407 | 29003 | 64466306 |
| Eczema | 22.68 | 20.04 | 16 | 3407 | 29704 | 64465605 |
| Eye swelling | 21.81 | 20.04 | 14 | 3409 | 22267 | 64473042 |
| Hepatic lesion | 21.66 | 20.04 | 9 | 3414 | 5815 | 64489494 |
| Chronic sinusitis | 20.99 | 20.04 | 9 | 3414 | 6283 | 64489026 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | D07AB08 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, PLAIN Corticosteroids, moderately potent (group II) |
| ATC | D07BB02 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS Corticosteroids, moderately potent, combinations with antiseptics |
| ATC | S01BA11 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFLAMMATORY AGENTS Corticosteroids, plain |
| FDA MoA | N0000175450 | Corticosteroid Hormone Receptor Agonists |
| FDA EPC | N0000175576 | Corticosteroid |
| MeSH PA | D000893 | Anti-Inflammatory Agents |
| CHEBI has role | CHEBI:35472 | anti-inflammatory drugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Otitis externa | indication | 3135009 | |
| Atopic dermatitis | indication | 24079001 | DOID:3310 |
| Crohn's disease | indication | 34000006 | |
| Contact dermatitis | indication | 40275004 | DOID:2773 |
| Seborrheic dermatitis | indication | 50563003 | DOID:8741 |
| Lichen simplex chronicus | indication | 53891004 | |
| Allergic rhinitis | indication | 61582004 | |
| Granuloma annulare | indication | 65508009 | DOID:3777 |
| Pruritus ani | indication | 90446007 | |
| Asthma | indication | 195967001 | DOID:2841 |
| Discoid lupus erythematosus | indication | 200938002 | |
| Plaque psoriasis | indication | 200965009 | |
| Scalp psoriasis | indication | 238608008 | |
| Pruritus of genital organs | indication | 267802000 | |
| Eruption of skin | indication | 271807003 | DOID:0050486 |
| Primary cutaneous T-cell lymphoma | indication | 400122007 | |
| Asthma management | indication | 406162001 | |
| Crohn's disease in remission | indication | 426549001 | |
| Allergic Rhinitis Prevention | indication | ||
| Chronic Non-Allergic Rhinitis | indication | ||
| Severe chronic obstructive pulmonary disease | off-label use | 313299006 | |
| Otitis Externa Eczema | off-label use | ||
| Otitis Externa Seborrhea | off-label use | ||
| Infection by Strongyloides | contraindication | 1214006 | DOID:10955 |
| Mycosis | contraindication | 3218000 | DOID:1564 |
| Ocular hypertension | contraindication | 4210003 | DOID:9282 |
| Gastritis | contraindication | 4556007 | DOID:4029 |
| Inactive tuberculosis | contraindication | 11999007 | |
| Epistaxis | contraindication | 12441001 | |
| Peptic ulcer | contraindication | 13200003 | DOID:750 |
| Hypercholesterolemia | contraindication | 13644009 | |
| Measles | contraindication | 14189004 | DOID:8622 |
| Disease caused by parasite | contraindication | 17322007 | |
| Cirrhosis of liver | contraindication | 19943007 | DOID:5082 |
| Arginase deficiency | contraindication | 23501004 | DOID:9278 |
| Glaucoma | contraindication | 23986001 | DOID:1686 |
| Acute tuberculosis | contraindication | 25629007 | |
| Viral disease | contraindication | 34014006 | DOID:934 |
| Immunosuppression | contraindication | 38013005 | |
| Hypertensive disorder | contraindication | 38341003 | DOID:10763 |
| Infectious disease | contraindication | 40733004 | |
| Hypothyroidism | contraindication | 40930008 | DOID:1459 |
| Hypokalemia | contraindication | 43339004 | |
| Hypercortisolism | contraindication | 47270006 | |
| Chronic heart failure | contraindication | 48447003 | |
| Cerebral malaria | contraindication | 53622003 | DOID:14069 |
| Tuberculosis | contraindication | 56717001 | |
| Perforation of tympanic membrane | contraindication | 60442001 | |
| Congenital hyperammonemia, type I | contraindication | 62522004 | |
| Osteoporosis | contraindication | 64859006 | DOID:11476 |
| Psychotic disorder | contraindication | 69322001 | |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Hypopituitarism | contraindication | 74728003 | DOID:9406 |
| Perforation of nasal septum | contraindication | 80142000 | |
| Hyperglycemia | contraindication | 80394007 | DOID:4195 |
| Open-angle glaucoma | contraindication | 84494001 | DOID:1067 |
| Bacterial infectious disease | contraindication | 87628006 | |
| Muscle atrophy | contraindication | 88092000 | DOID:767 |
| Herpes simplex | contraindication | 88594005 | DOID:8566 |
| Operation on nose | contraindication | 88733004 | |
| Bilateral cataracts | contraindication | 95722004 | |
| Seizure disorder | contraindication | 128613002 | |
| Disorder of muscle | contraindication | 129565002 | DOID:423 |
| Pulmonary tuberculosis | contraindication | 154283005 | DOID:2957 |
| Ophthalmic herpes simplex | contraindication | 186542001 | |
| Anastomosis of intestine | contraindication | 235407009 | |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Telangiectasia disorder | contraindication | 247479008 | |
| Edema | contraindication | 267038008 | |
| Pathological fracture | contraindication | 268029009 | |
| Diverticulitis of gastrointestinal tract | contraindication | 271366000 | |
| Cerebral trauma | contraindication | 275382005 | |
| Varicella-zoster virus infection | contraindication | 309465005 | |
| Osteopenia | contraindication | 312894000 | |
| Adrenal cortical hypofunction | contraindication | 386584007 | DOID:10493 |
| Avascular necrosis of bone | contraindication | 397758007 | DOID:10159 |
| Citrullinemia | contraindication | 398680004 | DOID:9273 |
| Atrophoderma | contraindication | 399979006 | |
| Peripheral vascular disease | contraindication | 400047006 | |
| Traumatic rupture of tendon | contraindication | 415749005 | |
| Exposure to varicella | contraindication | 444453009 | |
| Nasal Candidiasis | contraindication | ||
| Untreated Fungal Infection | contraindication | ||
| Uncontrolled Bacterial Infections | contraindication | ||
| Nasal Septal Ulcers | contraindication | ||
| Ornithine Carbamyltransferase Deficiency | contraindication | ||
| Nasal Trauma | contraindication | ||
| Arginosuccinate Lyase Deficiency | contraindication | ||
| Oropharyngeal Candidiasis | contraindication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 11.78 | acidic |
| pKa2 | 12.78 | acidic |
Orange Book patent data (new drug applications)
| Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05% | VERDESO | ALMIRALL | N021978 | Sept. 19, 2006 | RX | AEROSOL, FOAM | TOPICAL | 8962000 | Aug. 31, 2025 | TREATMENT OF ATOPIC DERMATITIS |
| 0.05% | VERDESO | ALMIRALL | N021978 | Sept. 19, 2006 | RX | AEROSOL, FOAM | TOPICAL | 9492384 | Aug. 31, 2025 | TREATMENT OF ATOPIC DERMATITIS |
| 0.05% | VERDESO | ALMIRALL | N021978 | Sept. 19, 2006 | RX | AEROSOL, FOAM | TOPICAL | 8460641 | Aug. 13, 2027 | TREATMENT OF ATOPIC DERMATITIS |
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Glucocorticoid receptor | Nuclear hormone receptor | AGONIST | CHEMBL | CHEMBL |
External reference:
| ID | Source |
|---|---|
| 4018267 | VUID |
| N0000146597 | NUI |
| D03696 | KEGG_DRUG |
| 4018267 | VANDF |
| C0011705 | UMLSCUI |
| CHEBI:204734 | CHEBI |
| CHEMBL1201109 | ChEMBL_ID |
| D003898 | MESH_DESCRIPTOR_UI |
| DB01260 | DRUGBANK_ID |
| 5311066 | PUBCHEM_CID |
| 7066 | IUPHAR_LIGAND_ID |
| 2889 | INN_ID |
| J280872D1O | UNII |
| 3254 | RXNORM |
| 1093 | MMSL |
| 4550 | MMSL |
| 002199 | NDDF |
| 412363005 | SNOMEDCT_US |
| 52215008 | SNOMEDCT_US |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0115-1517 | LOTION | 0.50 mg | TOPICAL | ANDA | 17 sections |
| desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0168-0309 | OINTMENT | 0.50 mg | TOPICAL | ANDA | 17 sections |
| desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0168-0310 | LOTION | 0.50 mg | TOPICAL | ANDA | 19 sections |
| DesOwen | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0299-5765 | LOTION | 0.50 mg | TOPICAL | ANDA | 18 sections |
| DesOwen | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0299-5770 | CREAM | 0.50 mg | TOPICAL | NDA | 18 sections |
| LoKara | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0462-0392 | LOTION | 0.50 mg | TOPICAL | ANDA | 18 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0472-0803 | LOTION | 0.50 mg | TOPICAL | ANDA | 19 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0472-0804 | CREAM | 0.50 mg | TOPICAL | NDA authorized generic | 19 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0713-0661 | CREAM | 0.50 mg | TOPICAL | ANDA | 18 sections |
| DESONATE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10922-828 | GEL | 0.50 mg | TOPICAL | NDA | 24 sections |
| Verdeso | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16110-111 | AEROSOL, FOAM | 0.50 mg | TOPICAL | NDA | 26 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16714-729 | CREAM | 0.50 mg | TOPICAL | ANDA | 21 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16714-828 | OINTMENT | 0.50 mg | TOPICAL | ANDA | 20 sections |
| DESONIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-944 | CREAM | 0.50 mg | TOPICAL | ANDA | 21 sections |
| Desonide Ointment, 0.05% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21922-004 | OINTMENT | 0.50 mg | TOPICAL | ANDA | 18 sections |
| DESONIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 24470-920 | GEL | 0.50 mg | TOPICAL | ANDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42254-142 | CREAM | 0.50 mg | TOPICAL | NDA | 20 sections |
| DESRX | HUMAN PRESCRIPTION DRUG LABEL | 1 | 44118-710 | GEL | 0.50 mg | TOPICAL | ANDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45802-422 | CREAM | 0.50 mg | TOPICAL | NDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45802-422 | CREAM | 0.50 mg | TOPICAL | NDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45802-423 | OINTMENT | 0.50 mg | TOPICAL | NDA | 20 sections |
| DESONATE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50222-504 | GEL | 0.50 mg | TOPICAL | NDA | 24 sections |
| DESONATE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50419-828 | GEL | 0.50 mg | TOPICAL | NDA | 24 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51672-1280 | CREAM | 0.50 mg | TOPICAL | ANDA | 21 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51672-1281 | OINTMENT | 0.50 mg | TOPICAL | ANDA | 21 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51672-4079 | LOTION | 0.50 mg | TOPICAL | ANDA | 21 sections |
| DESONIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52187-556 | GEL | 0.50 mg | TOPICAL | ANDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52565-038 | OINTMENT | 0.50 mg | TOPICAL | ANDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-3284 | CREAM | 0.50 mg | TOPICAL | NDA | 20 sections |
| Desonide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-4453 | OINTMENT | 0.50 mg | TOPICAL | NDA | 20 sections |